NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









ExpressionEdits

ExpressionEdits

Private
CambridgeHealthcare & Life Scienceshttps://www.expressionedits.com/

Last Round

Seed

May 29, 2024

Total Funding Raised

$13M

Company Overview

ExpressionEdits is a biotechnology company that offers a research platform aimed at enhancing transgene expression in mammalian systems to improve recombinant protein yields and the efficacy of DNA medicines.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Medical AI, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share

AI Layer

Application

Keywords

transgene designintronizationgene therapyprotein expressionsynthetic biologybiotech AIrecombinant proteingenetic engineeringdrug discoveryin silico designbiologicsAI-driven drug discoverygenomicsbio-design

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

ExpressionEdits Comparables

Compare ExpressionEdits with similar companies based on industry and business-model similarity.

ExpressionEdits comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Proteinea
72%
Ginkgo Bioworks
71%
ATUM
67%

ExpressionEdits Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedMay 29, 2024

Key People

Founding team and executive leadership

Kärt Tomberg

CEO And Co-Founder

Founding Team

Leopold Parts

Chief Technology Officer

Executive Team

ExpressionEdits Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 12, 2025

    Partnering to develop enhanced gene therapies.

ExpressionEdits Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

ExpressionEdits Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about ExpressionEdits's valuation, stock price, and market status.

Firmographic Details

HeadquartersCambridge
Employee Range26
Year Founded2021
Last FundingMay 29, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.